Effectiveness of Subcutaneously Administered Leuprolide Acetate to Achieve Low Nadir Testosterone in Prostate Cancer Patients

Evidence suggests lower nadir testosterone levels during the first year of androgen deprivation therapy improve advanced prostate cancer clinical outcomes. We evaluated pivotal trials for subcutaneously administered leuprolide acetate (1-, 3-, 4-, and 6-month doses) to determine nadir testosterone l...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Rev Urol
Autori principali: Pieczonka, Christopher M., Twardowski, Przemyslaw, Renzulli, Joseph, Hafron, Jason, Boldt-Houle, Deborah M., Atkinson, Stuart, Eggener, Scott
Natura: Artigo
Lingua:Inglês
Pubblicazione: MedReviews, LLC 2018
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168320/
https://ncbi.nlm.nih.gov/pubmed/30288142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3909/riu0798
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi